259 results on '"DI RESTA, CHIARA"'
Search Results
2. Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy
3. Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine
4. Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old
5. Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects
6. A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia
7. Melanocortin-1 receptor (MC1R): a review for dermatologists
8. SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome
9. New molecular approaches to Alzheimer's disease
10. Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients
11. Value-Based Health Care Implementation: The Case Study of mTBI Biomarkers.
12. Advance in Genomics of Rare Genetic Diseases
13. Editorial: Whole Genome Sequencing for rare diseases
14. Electrocardiogram Changes in the Postictal Phase of Epileptic Seizure: Results from a Prospective Study
15. Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells
16. The total testing process harmonization: the case study of SARS-CoV-2 serological tests.
17. Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench
18. Challenges of the Effectiveness of Traumatic Brain Injuries Biomarkers in the Sports-Related Context
19. A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies
20. Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study
21. Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma
22. 80 GENETIC MYOCARDITIS: ADVANCED WORKUP AND TREATMENT
23. Introduction to Ion Channels
24. Evaluation of damaging effects of splicing mutations: Validation of an in vitro method for diagnostic laboratories
25. EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015
26. Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy?
27. Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2
28. Exploratory assessment of serological tests to determine antibody titer against SARS‐CoV‐2: Appropriateness and limits
29. Current Updates on Expanded Carrier Screening: New Insights in the Omics Era
30. Genetic background of mitral valve prolapse
31. PP106 Links Between Accuracy And Effectiveness Of Laboratory Diagnostic Tests: Health Technology Assessment Of Two Analytical Approaches For Glycated Hemoglobin.
32. Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests
33. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy
34. Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
35. High-throughput genetic characterization of a cohort of Brugada syndrome patients
36. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
37. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign
38. Generation of a Triadin KnockOut Syndrome Zebrafish Model
39. Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
40. The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects
41. Brugada syndrome genetics is associated with phenotype severity
42. Increased sensitivity of the neuronal nicotinic receptor alpha2 subunit causes familial epilepsy with nocturnal wandering and ictal fear
43. Increased Sensitivity of the Neuronal Nicotinic Receptor α2 Subunit Causes Familial Epilepsy with Nocturnal Wandering and Ictal Fear
44. Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy
45. Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing
46. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization
47. Brugada syndrome genetics is associated with phenotype severity
48. Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests
49. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study
50. Novel SCN5A p.V1429M Variant Segregation in a Family with Brugada Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.